Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences
about
Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virusRetroviruses have differing requirements for proteasome function in the budding processLocalization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor proteinCytoskeletal proteins inside human immunodeficiency virus type 1 virionsNucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteinsNucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activityInhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteinsAnalysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase.Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid proteinReplacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral proteaseHelical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packagingC-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism.Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin.Identification of retroviral late domains as determinants of particle size.Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling.Analysis of the contribution of reverse transcriptase and integrase proteins to retroviral RNA dimer conformation.Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides.A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assemblyCryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop.Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly.Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays.Particle size determinants in the human immunodeficiency virus type 1 Gag proteinAnalysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.Assembly and processing of human immunodeficiency virus Gag mutants containing a partial replacement of the matrix domain by the viral protease domainKinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates.Molecular requirements for human immunodeficiency virus type 1 plus-strand transfer: analysis in reconstituted and endogenous reverse transcription systems.The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.Detection of human immunodeficiency virus type 1 nucleocapsid protein p7 in vitro and in vivo.On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch?Secondary structure and secondary structure dynamics of DNA hairpins complexed with HIV-1 NC proteinFundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implicationsThe late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles.Equine infectious anemia virus and the ubiquitin-proteasome system.
P2860
Q24523226-E78B36D4-A678-4011-93A5-4A6BFBFBCBBBQ24550599-71DBF552-22E8-4151-BC72-B752E661AE58Q24645706-327D8E35-2B2B-449A-9D1B-D50E6C20CA91Q24680106-6654DEAE-50A4-4962-B7E4-7ECABCFC7DA8Q25257759-725EFFE7-AC08-4396-B7B0-3FC6B5C30DBEQ27642042-90391246-A885-44C5-8172-EA597156EE7DQ28378778-750A6AAA-F5D6-4991-B8C1-3940EA92B585Q28379468-C442B008-4B25-4487-BC4A-E3027B4217A4Q30423782-C76D3803-BF07-49BB-90FE-7F2B39F52570Q30453495-D47492AF-C6D8-40DF-9B3F-AB747AD5E1FEQ30850215-AEB74F7C-F02C-43A3-ADE4-58947178A7D2Q30980940-E049ED36-18D4-4E19-9054-768E97B08D58Q33581258-73C7E555-4E4B-4C84-9CB3-AECC4FB86976Q33638655-1212684A-4C19-46B9-A43E-7C6F9FB42FA7Q33643700-12F68162-46FB-45CF-B27D-12405DEA3C52Q33653548-54E903D4-6945-46E9-8509-241470D969A3Q33707507-C889A2A5-56B8-4505-A500-9F7B08C9A228Q33780519-3EE574CC-89A4-4F9E-9CC8-4D7670893E6CQ33782263-D8527C17-85E2-4775-937A-D9BF4645778AQ33782302-A2A9075C-D875-4D30-A805-83EBCA9433E7Q33782377-84911156-0854-4A12-9E47-55C90815EC62Q33782886-4C5DFA34-52B4-44EC-A88A-DA5D5EEE9C55Q33783498-58836EED-BE08-4669-9FE4-22A660FB3EF1Q33783618-01F6E10E-782D-48B7-97CF-80054BABF29AQ33783955-0D6C53BC-035D-4D58-AD3C-0227D2D6117FQ33784754-3F90B07A-EC52-47B6-80C8-452E98387388Q33791156-D8096D39-ABF9-4E70-9F9E-E1DEAE3B5FFFQ33801779-A5287329-12F7-4BCA-A605-24AE0F4F1654Q33806395-41C312CD-EB22-4320-BD6C-93FD06ABCA00Q33813827-A1FCA8F5-F2F8-48DF-B4D6-58D207699921Q33841842-111C8E7A-B14F-46EC-B1A6-8621E160B8B0Q33845445-852867E9-DECD-4484-8550-97DC50369CA8Q33845811-48B09E26-A25E-42B5-B438-1971A4C132F4Q33911895-DD83781F-A0FF-498E-9BD6-3571E710BBB7Q33958026-86F12872-BB94-4B5A-B5C0-0611F0CAA30EQ34164929-2DBC1BFE-3BD1-45AF-B690-097E9390D2B2Q34187402-3992ACFD-4BF0-45A1-9C32-CB23FCB487A5Q34237075-12115B36-258C-4F7C-A8AB-F9EAEBC534E9Q34329950-0077E516-04E2-4F50-BF32-071B5CB91C5FQ34332683-C9602CB1-A883-4AAD-B7A2-C5F588E002B8
P2860
Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Gag proteins of the highly rep ...... complete amino acid sequences
@ast
Gag proteins of the highly rep ...... complete amino acid sequences
@en
type
label
Gag proteins of the highly rep ...... complete amino acid sequences
@ast
Gag proteins of the highly rep ...... complete amino acid sequences
@en
prefLabel
Gag proteins of the highly rep ...... complete amino acid sequences
@ast
Gag proteins of the highly rep ...... complete amino acid sequences
@en
P2093
P2860
P1433
P1476
Gag proteins of the highly rep ...... complete amino acid sequences
@en
P2093
C Fenselau
D G Johnson
D K Bryant
L E Henderson
L O Arthur
M A Bowers
R C Sowder
S A Serabyn
P2860
P304
P407
P577
1992-04-01T00:00:00Z